جست‌وجوی استاد و پژوهشگر

• Pediatric Anesthesiology
• Cardiac Anesthesia
• Liver Transplant Anesthesia
• +۶ مورد دیگر

Dr. John P. Scott is a Professor of Anesthesiology and Pediatrics at the Medical College of Wisconsin, serving as Division Chief of Pediatric Anesthesiology at Children's Wisconsin. He holds dual appointments in both the Department of Anesthesiology and the Department of Pediatrics, with specialization in Pediatric Critical Care. Dr. Scott directs the Pediatric Liver Transplant Anesthesia program and serves as Associate Program Director for the Combined Pediatrics and Anesthesiology Residency Training Program. Dr. Scott's research focuses on improving outcomes for children undergoing congenital heart surgery, with particular expertise in hemostasis management during cardiopulmonary bypass, near-infrared spectroscopy monitoring, and the use of cell-free DNA as a biomarker for predicting adverse outcomes. His work has been instrumental in advancing the understanding of inflammatory responses in infant heart surgery, most notably through his involvement in the landmark STRESS trial. His publication record demonstrates a clear progression from foundational research on coagulation disorders and monitoring techniques to large-scale clinical trials and biomarker discovery. The most recent publications (2023-2025) focus on sub-analyses of the STRESS trial data, novel applications of cell-free DNA biomarkers, and optimization of anesthesia techniques for complex congenital heart conditions. Summa Cum Laude, University of Notre Dame (1995) Phi Beta Kappa (1996) Alpha Omega Alpha, University of Wisconsin School of Medicine and Public Health (1999) Ernest O. Henschel MD Memorial Outstanding Resident Award (2004) James R. Schmidt MD Memorial Chief Resident Award (2006) Milwaukee Magazine's Top-Rated Doctors (2013-2014) Best Doctors (2015-2020) Dr. Scott has successfully mentored numerous residents and fellows through the Combined Pediatrics and Anesthesiology Residency program. His research is supported by multiple grants including an NIH UO1-funded clinical trial and an AHW-Research and Education Program grant focused on cell-free DNA biomarkers. He has developed innovative clinical programs including the Pediatric Cardiac Surgical Home, which has improved postoperative outcomes for children with congenital heart disease. As Division Chief of Pediatric Anesthesiology, Dr. Scott leads a multidisciplinary team focused on providing specialized anesthesia care for children undergoing complex surgical procedures, particularly in cardiac surgery and liver transplantation. His laboratory research focuses on identifying biomarkers that can predict adverse outcomes following pediatric cardiac surgery, with the goal of developing targeted interventions to improve patient safety.

• Thrombosis and Hemostasis
• Laboratory Medicine
• Pathology
• +۷ مورد دیگر

Dr. Andrew J. Goodwin IV, M.D. serves as Professor and Interim Chair of Pathology and Laboratory Medicine at the Larner College of Medicine at the University of Vermont. His leadership roles include Vice Chair of Quality and Clinical Affairs, Division Chief for Laboratory Medicine, Medical Director for the Coagulation Laboratory, and Director for Faculty Recruitment and Retention. As an American Board of Pathology certified pathologist in both Anatomic and Clinical Pathology, Dr. Goodwin maintains clinical responsibilities as Section Medical Director of Thrombosis & Hemostasis at the University of Vermont Medical Center and as a CLIA Laboratory Medical Director across multiple institutions in Vermont, northern New York, and New Hampshire. Dr. Goodwin's research focuses on laboratory thrombosis and hemostasis, with publications spanning quality laboratory testing for thrombotic and hemostatic diseases. His work addresses critical issues in anticoagulant monitoring, D-dimer testing methodologies, von Willebrand factor assays, and point-of-care testing validation. He has also made significant contributions to surgical pathology, particularly in breast and cervical pathology. Recognized nationally for contributions to laboratory quality and accreditation, Dr. Goodwin serves on the Council for Scientific Affairs for the College of American Pathologists. His leadership extends to educational innovation, having created the Laboratory Management Course Curriculum in 2014 to train pathology residents in operational and regulatory aspects of laboratory medicine. As Interim Chair, Dr. Goodwin champions strategic initiatives including digital anatomic pathology with AI integration, laboratory stewardship for genomic medicine testing, and creative funding opportunities to support innovative research and education. His current focus emphasizes advancing patient care through innovation, collaboration, and service while maintaining the department's mission of quality clinical care, effective education, and well-funded research. Dr. Goodwin has received multiple teaching awards for his dedication to medical education and has mentored numerous trainees and faculty throughout his career. His scholarly work appears in prominent journals including the New England Journal of Medicine, Archives of Pathology & Laboratory Medicine, and American Journal of Hematology.

• Hematology
• Coagulation Disorders
• Transfusion Medicine
• +۵ مورد دیگر

Dr. Jun Teruya is a faculty member at Baylor College of Medicine in the Department of Pathology & Immunology with clinical practice at Texas Children's Hospital. His academic appointment appears to be in the School of Medicine, with strong affiliations to the Department of Pediatrics, particularly the Hematology/Oncology division. Dr. Teruya's research focuses on coagulation disorders, anticoagulation monitoring, and transfusion medicine, with particular emphasis on pediatric populations. His work addresses critical challenges in managing hemostasis in children requiring extracorporeal membrane oxygenation (ECMO), ventricular assist devices, and other complex medical interventions. He has made significant contributions to understanding platelet function disorders in adolescents with menorrhagia and improving diagnostic approaches for bleeding disorders. Analyzing his publication record from 2002-2015 reveals consistent productivity in high-impact hematology and laboratory medicine journals. His research demonstrates an evolution from foundational studies in coagulation testing to more clinically applied research addressing specific challenges in pediatric critical care hemostasis. The most recent publications focus on practical clinical questions regarding anticoagulation monitoring, point-of-care testing, and age-specific hemostatic parameters. Dr. Teruya maintains an active research program with Department of Defense funding for developing point-of-care platelet function assessment technology. His work bridges laboratory medicine and clinical hematology, with strong emphasis on translating diagnostic findings into improved patient care, particularly for vulnerable pediatric populations requiring complex medical interventions. His laboratory work centers on the Coagulation and Hemostasis Research Laboratory, where he investigates diagnostic methodologies and their clinical applications in bleeding and thrombotic disorders. This research environment supports both basic science investigations of hemostatic mechanisms and clinical studies evaluating diagnostic approaches in real-world settings.

• Medical Genetics
• Neurodevelopmental Disorders
• Epilepsy Genetics
• +۵ مورد دیگر

Sinem YALÇINTEPE is an Associate Professor in the Department of Medical Genetics at Trakya University Faculty of Medicine, where she has been working since 2022. She earned her medical degree from Ege University School of Medicine in 2009 and has established herself as a prominent researcher in medical genetics with a focus on neurodevelopmental disorders, epilepsy genetics, and chromosomal abnormalities. Her research interests span multiple areas of medical genetics, with particular emphasis on neurodevelopmental disorders, epilepsy genetics, chromosomal abnormalities, thrombophilia and pregnancy loss, and next-generation sequencing applications. She has made significant contributions to understanding the genetic basis of various conditions including Desanto-Shinawi Syndrome, Jacobsen Syndrome, and various neurodevelopmental disorders. Her work frequently involves applying advanced genomic techniques to improve diagnostic accuracy and understand genotype-phenotype correlations. Analysis of her recent publications reveals a strong trend toward applying next-generation sequencing technologies to diagnose and understand complex genetic disorders. Her research spans from fundamental genetic mechanisms to clinical applications, with particular focus on neurodevelopmental conditions, epilepsy syndromes, and chromosomal disorders. She has made notable contributions to understanding rare genetic syndromes in the Turkish population and has published extensively on the application of genomic technologies in clinical diagnostics. Dr. YALÇINTEPE actively collaborates with national and international researchers through consortia such as the National Genetics Consortium. Her work demonstrates strong integration between basic research and clinical applications, with numerous publications focusing on translating genetic findings into improved diagnostic approaches and potential therapeutic strategies.

• Critical Care Medicine
• Anaesthesiology
• Pulmonary Microbiome
• +۵ مورد دیگر

Ronni Thermann Reitz Plovsing serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, specializing in Anaesthesiology. Based at Blegdamsvej 3 in Copenhagen, Dr. Plovsing maintains an active research profile with significant contributions to critical care medicine. Research interests span multiple critical domains including pulmonary microbiome analysis in ARDS, cerebral autoregulation monitoring, and the complex interplay between coagulation disorders and critical illness. Recent work demonstrates particular focus on COVID-19 pathophysiology and treatment challenges, with numerous nationwide Danish studies examining long-term outcomes and complications in ICU patients. Analysis of recent publications reveals strong methodological expertise in systematic reviews and large-scale observational studies, with particular attention to translational research bridging preclinical models and clinical applications. The research portfolio shows consistent progression from fundamental physiological investigations to population-level healthcare impact assessments. Professional activities include collaborations with multiple Danish intensive care units and research groups, contributing to national efforts in critical care epidemiology and therapeutic development.

• Anaesthesiology
• Intensive Care Medicine
• Sepsis and Septic Shock
• +۴ مورد دیگر

Frank Christian Pott is a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen, with a specialization in Anaesthesiology. His work is affiliated with the Department of Clinical Medicine and he is based at Bispebjerg Bakke 23, 2400 København NV and Blegdamsvej 3, 2200 København N. Dr. Pott's research interests focus on critical care medicine, particularly in the areas of sepsis, cardiovascular physiology during anesthesia, cerebral autoregulation in stroke patients, and coagulation disorders. His work bridges clinical practice with physiological research to improve patient outcomes in intensive care settings. His expertise spans anaesthesiology, intensive care medicine, and hemodynamic monitoring in critically ill patients. His recent publications demonstrate a strong focus on septic shock management, cerebral hemodynamics in stroke patients, and cardiovascular responses to body positioning during anesthesia induction. Dr. Pott has made significant contributions to understanding endothelial function in sepsis and coagulation dynamics in critically ill patients, with his 2015 study on biomarkers of endothelial injury in severe sepsis accumulating over 100 citations. Extensive research in sepsis pathophysiology and management Significant contributions to cerebral autoregulation monitoring Expertise in cardiovascular responses to positioning during anesthesia Research on coagulation disorders in critical illness Dr. Pott collaborates with leading researchers in critical care medicine across multiple institutions, contributing to high-impact publications in prestigious journals such as Transfusion, Critical Care, and Intensive Care Medicine. His work has garnered attention across academic platforms and social media, reflecting its relevance to clinical practice.

Scott D. Olsonمشاهده پروفایل

دانشیار

• Mesenchymal stem cell therapies
• Immunomodulation
• Traumatic Brain Injury treatment
• +۵ مورد دیگر

Dr. Scott D. Olson is an Associate Professor at the University of Texas Health Science Center in the Department of Pediatric Surgery, where he has been conducting research since September 2011. His academic journey includes a BS in Biochemistry from Texas Christian University, a PhD in Molecular and Cellular Biology from Tulane University, and postdoctoral training in the Stem Cell Program at University of California at Davis Health System. Dr. Olson's research centers on mesenchymal stem cells (MSCs) and their therapeutic applications, particularly for Traumatic Brain Injury (TBI). His work explores how MSCs can immunomodulate and restore homeostasis, with a focus on their impressive ability to control immune system activation in inflammatory conditions. His laboratory conducts comparative studies of different MSC preparations to identify optimal therapeutic candidates and investigates MSC interactions with immune cells, particularly monocytes and macrophages. Dr. Olson's research program has evolved from studying MSC applications for Huntington's Disease at UC Davis to focusing on TBI treatment at UTHealth. His work demonstrates a consistent theme of leveraging MSCs' innate therapeutic abilities to develop improved cellular therapies. The research shows particular promise in conditions involving prolonged or exaggerated inflammation, where MSCs have demonstrated significant efficacy in clinical trials. His scientific contributions span multiple disciplines including regenerative medicine, neurology, immunology, and trauma surgery. Dr. Olson has published extensively on MSC therapies, with recent work expanding into synthetic biology approaches and novel drug delivery systems. His collaborative research extends across multiple institutions and specialties, reflecting the interdisciplinary nature of modern regenerative medicine research. Dr. Olson's laboratory focuses on three primary research directions: Comparing different MSC and MSC-like cell preparations to identify optimal therapeutic candidates Studying MSC interactions with specific immune cell populations, particularly their influence on monocyte and macrophage phenotype Developing mixed cell preparations using selectively permeable scaffolds for implantable therapeutic constructs His work aims to translate basic MSC research into clinical applications, with a particular emphasis on improving treatments for Traumatic Brain Injury through better understanding of MSC mechanisms and therapeutic potential.

Moua Yangمشاهده پروفایل

استادیار

• Thrombosis Mechanisms
• Redox Biology
• Oxidative Cysteine Modification
• +۵ مورد دیگر

Moua Yang, Ph.D. is an Academic Assistant Professor in the Division of Hematology and Oncology at the University of Washington School of Medicine and an Assistant Member at the Bloodworks Northwest Research Institute in Seattle, Washington. His research focuses on redox mechanisms in thrombosis, with particular emphasis on oxidative cysteine modifications and thiol isomerases in clot formation. Dr. Yang received his undergraduate degree from the University of Wisconsin-Stevens Point, followed by a Ph.D. from the Medical College of Wisconsin. He completed postdoctoral training at the Medical College of Wisconsin and later at Beth Israel Deaconess Medical Center and Harvard Medical School. Dr. Yang's primary research investigates the redox mechanisms that promote thrombosis, with specific focus on oxidative cysteine modification and its role in thrombotic machinery. His laboratory employs chemical biology, protein biochemistry, and real-time intravital imaging to unravel these mechanisms. He also studies thiol isomerases - enzymes that function to make and break disulfides during protein folding - which escape into the bloodstream and play critical roles in clot formation. His research explores how these enzymes promote thrombus formation in oxidative stress conditions, with specific areas of study including mechanisms of vaso-occlusion by thiol isomerases and natural compounds as anti-thrombotics. Analysis of Dr. Yang's recent publications reveals a strong focus on redox biology in thrombosis, with particular emphasis on cysteine oxidation, thiol isomerases, and CD36 signaling pathways. His work spans basic mechanisms of thrombosis, translational applications for antithrombotic therapy, and even extends to research on high-altitude physiology and diversity in STEMM fields. A notable trend is his exploration of natural compounds, particularly polyphenols, as potential antithrombotic agents targeting redox-sensitive pathways. Dr. Yang leads a research laboratory at Bloodworks Northwest Research Institute, where he mentors research technologists including Osamede C. Owegie and John K. Ryan. His laboratory investigates the molecular mechanisms of thrombosis with applications for developing novel antithrombotic therapies.

Stephan Mollمشاهده پروفایل

استاد

• Blood clots
• Anticoagulation
• Thrombophilia
• +۶ مورد دیگر

Dr. Stephan Moll is a Professor of Medicine in the Department of Medicine, Division of Hematology at the University of North Carolina at Chapel Hill School of Medicine. His clinical practice focuses on coagulation and classical hematology, with particular expertise in thrombosis and anticoagulation. He serves as Medical Director of the UNC Blood Clot Education Program Clot Connect and leads the UNC Athletes and Blood Clots Program. Dr. Moll received his medical degree from Freiburg University in Germany. He completed his internship and residency in internal medicine and a hematology-oncology fellowship at Duke University Medical Center (1989-1996), including a clinical coagulation fellowship at UNC Chapel Hill (1994-1995). Prior to joining UNC in 1999, he worked in clinical coagulation at Humboldt University in Berlin, Germany (1997-1999). His primary research interests include clinical trials on new anticoagulants, optimizing established anticoagulant therapies, antiphospholipid antibody syndrome, and postthrombotic syndrome. Dr. Moll has a special focus on unusual thromboses (cerebral/sinus vein, retinal vessel, splanchnic vein thrombosis) and unusual thrombophilias (antiphospholipid antibodies, rare compound thrombophilias). A major professional commitment is clinical-medical education of patients, healthcare professionals, and the public about blood clots and clotting disorders. Analysis of Dr. Moll's recent publications reveals a consistent focus on venous thromboembolism management across diverse patient populations including obese patients, cancer patients, and athletes. His work spans clinical trials, consensus guidelines, and patient-centered research examining preferences and concerns regarding anticoagulation therapy. The research demonstrates expertise in both clinical management and educational aspects of thrombosis care. Dr. Moll is a co-founder of the National Blood Clot Alliance (NBCA) and serves on the board of the Anticoagulation Forum (AC-Forum). He has authored numerous peer-reviewed articles and textbook chapters on blood clotting disorders and has maintained a Q/A section on thrombosis for the non-profit website fvleiden.org since 2001. He founded the UNC Blood Clot Education Outreach Program (Clot Connect) in 2010 and established the Athletes and Blood Clots Program with three primary goals: providing comprehensive care to athletes with blood clots, creating educational resources for athletes and their support teams, and supporting research in this specialized area. Dr. Moll is deeply committed to mentoring trainees in hematology and coagulation-related fields.

Micah Mooberryمشاهده پروفایل

دانشیار

• Hematology
• Coagulation Disorders
• Thrombosis
• +۳ مورد دیگر

Micah Mooberry, MD is an Associate Professor of Medicine in the Division of Hematology within the Department of Medicine at the University of North Carolina at Chapel Hill School of Medicine. His clinical and research work focuses on the intersection of coagulation disorders and inflammatory conditions, with particular expertise in thrombotic complications. Dr. Mooberry's research interests center on the investigation of the coagulation system in inflammatory disorders with a thrombotic phenotype. His work specifically examines the interplay between inflammation and coagulation, with a focus on understanding why certain inflammatory conditions predispose to thrombosis. His research has particularly emphasized inflammatory bowel disease, which affects predominantly adolescents and young adults and carries an associated increased risk of thrombosis. Much of his research effort has also focused on microparticles and their potential role in coagulation activation and thrombotic risk in disease states, with special interest in the evaluation of microparticles by flow cytometry for both enumeration and characterization according to cell of origin. His recent publications demonstrate ongoing research in venous thromboembolism, hemophilia treatment, sickle cell disorders, and the effects of pathogen inactivation on blood products. His work spans basic science investigations of coagulation mechanisms to clinical studies examining thrombotic risk in various patient populations. Professional Recognition: Mentored Research Award from the Hemostasis and Thrombosis Research Society Dr. Mooberry maintains an active research program with collaborative efforts aimed at standardizing and refining flow cytometric techniques in microparticle analysis to improve understanding of their potential role in disease processes. His work has significant implications for understanding thrombotic risk in inflammatory conditions and developing better diagnostic and therapeutic approaches.

• Hematology
• Bleeding Disorders
• Hemophilia
• +۴ مورد دیگر

Frank W.G. Leebeek serves as a Full Professor in the Department of Hematology at Erasmus University Rotterdam's Erasmus MC. With an extensive research portfolio comprising 482 publications, he maintains active collaborations across international institutions as evidenced by his extensive network map. His work has attracted significant attention with mentions in news outlets, social media platforms, and academic readership. Professor Leebeek's research primarily focuses on bleeding disorders, with particular expertise in hemophilia and von Willebrand disease. His work spans clinical phenotyping, pathophysiological mechanisms, gene therapy development, and diagnostic methodology. Key research areas include von Willebrand factor analysis, pharmacokinetics of clotting factors, platelet function disorders, and the clinical manifestations of bleeding disorders that don't always correlate with laboratory measurements. Analysis of his recent publications reveals a strong emphasis on translational research bridging laboratory findings with clinical applications. His work increasingly incorporates proteomics, gene therapy approaches, and novel diagnostic methodologies to address unmet needs in bleeding disorder management. Notably, his research demonstrates consistent collaboration with international consortia such as the SYMPHONY consortium. Professor Leebeek has supervised 30 research projects throughout his career, indicating a substantial commitment to academic mentorship. His research has generated significant scholarly attention with multiple citations in Scopus-indexed journals and engagement across social media platforms including X (Twitter), Facebook, and Bluesky.

• Hematology
• Thrombosis and Hemostasis
• Stroke
• +۳ مورد دیگر

Moniek P.M. de Maat is a Full Professor in the Department of Hematology at Erasmus University Rotterdam, specializing in thrombosis, hemostasis, and cardiovascular disease mechanisms. Her work bridges molecular coagulation research with clinical applications in stroke and bleeding disorders. Her research portfolio centers on: Fibrinogen variants in ischemic stroke pathogenesis Von Willebrand factor dynamics in mechanical circulatory support Platelet function diagnostics for bleeding disorders Anticoagulation monitoring in cardiac interventions Biofilm development in cardiovascular infections Recent publications reveal a translational focus on diabetes-stroke links, LVAD complications, and rapid diagnostic testing, emphasizing biomarker discovery and clinical risk stratification. She has supervised 11 students, contributing to hematology training and research capacity in coagulation science.

• Hematology
• Hemostasis
• Laboratory Medicine
• +۱ مورد دیگر

Kristi Lew serves as an Associate Professor in the Department of Laboratory Medicine & Pathology at the University of Alberta's Faculty of Medicine & Dentistry, where she holds a core academic appointment focused on laboratory medicine education and clinical pathology. Her research and teaching expertise centers on hematology and hemostasis, with deep specialization in blood cell morphology, structure, and function. She investigates malignant conditions like leukemia, benign disorders including anemia, and coagulation pathologies, developing diagnostic methodologies for clinical laboratory applications. Her work bridges theoretical knowledge with practical hemostasis testing protocols to advance diagnostic precision in medical laboratory science.

• Fetal therapy
• twin pregnancy
• placental dysfunction
• +۲ مورد دیگر

Venu Jain is a Professor in the Department of Obstetrics and Gynaecology at the University of Alberta's Faculty of Medicine & Dentistry, specializing in high-risk pregnancy management and evidence-based clinical guidelines. His work focuses on translating research into practical obstetric care standards across Canada. Education: Medical Degree: Government Medical College, Punjabi University, India (1992) Residency: University of Texas, Medical Branch, Galveston Fellowship: Mt. Sinai Hospital, University of Toronto Research Focus: Professor Jain's investigations target critical areas including fetal therapy interventions , complications in twin pregnancies , placental pathophysiology , predictive models for pre-eclampsia , and systemic improvements in obstetric care delivery . His approach integrates clinical practice with quality improvement frameworks to address preventable maternal-fetal morbidity. Publication Trends: His 15 most recent publications (2021-2025) demonstrate dominant leadership in national guideline development through the Society of Obstetricians and Gynaecologists of Canada (SOGC). Key thematic clusters include hypertensive disorders management (37% of works), twin pregnancy protocols (13%), fetal surveillance standards (20%), and diagnostic innovations like point-of-care ultrasound (7%). Notably, 60% of his publications directly shape Canadian clinical practice through formal SOGC guidelines. Scientific Recognition: While specific awards aren't documented in the source material, his consistent role as lead or contributing author on SOGC guidelines represents significant peer-recognized expertise in obstetric medicine. Academic Contributions: As a full-time professor, Jain actively shapes obstetric training and policy despite no student listings in the provided text. His guideline work inherently involves cross-institutional collaboration with provincial health authorities and national medical bodies to standardize care pathways. Current projects focus on implementing preeclampsia prediction models and optimizing fetal monitoring protocols across Alberta's healthcare system. Clinical Integration: His research operates at the direct patient-care interface through the University of Alberta's obstetrics department, where findings are rapidly translated into clinical algorithms used in Edmonton's tertiary maternity centers and disseminated province-wide through continuing medical education initiatives.

Sven Olsonمشاهده پروفایل

استادیار

• Hematology
• Thrombosis Research
• Bleeding Disorders
• +۵ مورد دیگر

Sven Olson is an Assistant Professor in the Department of Medicine at Oregon Health & Science University (OHSU) School of Medicine. He provides clinical care at Doernbecher Children's Hospital and the OHSU Knight Cancer Institute's Center for Health & Healing, specializing in hematologic diseases with emphasis on bleeding and clotting disorders. His educational background includes a B.S. from the University of Wisconsin-Madison (2010), M.D. from the Medical College of Wisconsin (2014), Internal Medicine residency at OHSU (2017), and Hematology/Oncology fellowship at OHSU (2020). Dr. Olson's research focuses on thrombosis mechanisms, particularly the Contact Activation System, with clinical interests spanning venous/arterial thrombosis, hemophilia, von Willebrand disease, and platelet disorders. His laboratory work investigates novel anticoagulant targets and device-related thrombosis. Analysis of his 15 most recent publications (2020-2024) reveals a strong focus on translational thrombosis research, with recurring themes in anticoagulant development, ECMO complications, cancer-associated thrombosis, and iron deficiency management. His work bridges basic science (microfluidics, antibody development) with clinical applications (dialysis, travel medicine, electronic consultations). Professional recognition includes board certification in Internal Medicine (2017) and Hematology (2020). His affiliations span: American College of Physicians American Society of Hematology American Society of Clinical Oncology Hemostasis & Thrombosis Research Society Dr. Olson actively participates in clinical research through multicenter trials (e.g., iron therapy studies) and leads laboratory investigations into coagulation pathways. His patient-centered approach is reflected in high satisfaction scores (4.9/5 from 43 ratings), with personal interests including outdoor activities and cooking with his family.